Aradigm (Enterprise Systems (Healthcare))

Website
Current Valuation
$106.0M
As of December 9, 2025
Total Funding Raised
$25.0M
Last Round
Early Stage VC

$20.0M

Last Funding
Dec 2025

Funding date

Capital Efficiency
4.24x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Aradigm (Enterprise Systems (Healthcare)) is currently valued at $106.0M as of December 9, 2025. The company has raised a total of $25.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 4.24x, Aradigm (Enterprise Systems (Healthcare)) has achieved a valuation that is 4.24 times the total capital raised.

Track Aradigm (Enterprise Systems (Healthcare)) Valuation Updates

Get notified when Aradigm (Enterprise Systems (Healthcare)) raises new funding or valuation changes

Explore More Data
Detailed analysis for Aradigm (Enterprise Systems (Healthcare))

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Aradigm (Enterprise Systems (Healthcare))'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Aradigm (Enterprise Systems (Healthcare)) Worth in 2026?

Aradigm (Enterprise Systems (Healthcare)) is a leading private company in the technology sector. Track Aradigm (Enterprise Systems (Healthcare))'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Aradigm (Enterprise Systems (Healthcare)) Valuation is Determined

Private company valuations like Aradigm (Enterprise Systems (Healthcare))'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.